SCHEMBL21084307

SCHEMBL21084307

NS(=O)(=O)c1cnc2ccc(Br)cn12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.47
TNF P01375 2/20 0.46
MAP3K14 Q99558 1/20 0.44
PIK3CA P42336 3/20 0.39
MTOR P42345 2/20 0.39
CA2 P00918 2/20 0.37
ADORA2A P29274 1/20 0.35
PIK3CG P48736 1/20 0.35
FLT3 P36888 2/20 0.34
MET P08581 1/20 0.34
PIK3CD O00329 1/20 0.34
DYRK3 O43781 1/20 0.34
CCNT1 O60563 1/20 0.34
CDK2 P24941 1/20 0.34
PIK3CB P42338 1/20 0.34
CSNK1E P49674 1/20 0.34
CLK1 P49759 1/20 0.34
CLK2 P49760 1/20 0.34
CLK3 P49761 1/20 0.34
GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18766632 0.83 MAP3K14 (0.41) TGFBR1TNFMAP3K14PIK3CAMTOR
SCHEMBL18785910 0.83 PIK3CA (0.42) TGFBR1MAP3K14PIK3CAMTORADORA2A
SCHEMBL17697688 0.83 MAP3K14 (0.41) TGFBR1TNFMAP3K14PIK3CAMTOR
SCHEMBL24803785 0.81 ADORA2A (0.41) TGFBR1MAP3K14PIK3CAMTORADORA2A
SCHEMBL21083345 0.80 TGFBR1 (0.53) TGFBR1TNFMAP3K14CA2MET
SCHEMBL18766649 0.77 GAA (0.39) TNFMAP3K14PIK3CAMTORADORA2A
SCHEMBL3846731 0.77 CA2 (0.51) MAP3K14PIK3CAMTORCA2CDK2
SCHEMBL23873085 0.76 TGFBR1 (0.47) TGFBR1TNFCA2FLT3MET
SCHEMBL23872984 0.76 TGFBR1 (0.47) TGFBR1TNFCA2METCA12
SCHEMBL18766610 0.76 GAA (0.41) TNFADORA2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3492461-A1 NITROGENOUS HETEROCYCLIC AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION THEREOF Shanghai Yingli Pharmaceutical Co. Ltd. (CN) 2019-06-05 EP disclosed